The purpose of this study is to examine the effect of dutasteride on the inhibition of
low-risk, localized prostate cancer progression in men who would otherwise receive no active
therapy (expectant management).
Inclusion criteria:
- Must be male ≥48 and ≤82 years of age
- Have biopsy proven, low-risk, localized prostate cancer and active in expectant
management not more than 14 months. [For the purposes of assessing subject
eligibility a diagnostic biopsy must have included at least 10 cores, (< 4 cores
positive and <50% of any one core positive) and must have been obtained within 8
months of screening]. If a saturation biopsy was performed (20 or more cores
obtained) 2-3 cores are to be positive for prostate cancer and with <50% of any one
core positive. Initial diagnosis of T1a/T1b obtained during a TURP is not allowed.
- Gleason score ≤6 [Gleason pattern 4 or above must not be present on any biopsy
(initial or entry)]
- Clinical stage T1c-T2a
- Serum PSA ≤11ng/mL. If the screening PSA value from the central laboratory is greater
than 11ng/ml, one PSA retest is allowed through the central laboratory
- A life expectancy greater than five years.
- Able to swallow and retain oral medication
- Able and willing to participate in the full 3 years of the study
- Able to read and write (health outcomes questionnaires are self-administered),
understand instructions related to study procedures and give written informed
consent.
Exclusion criteria:
- Subject has ever been treated for prostate cancer with any of the following:
- Radiotherapy (external beam or brachytherapy)
- Chemotherapy
- Hormonal therapy (e. g., megestrol, medroxyprogesterone, cyproterone, DES)
- Oral glucocorticoids
- GnRH analogues (e. g., leuprolide, goserelin)
- Glucocorticoids, except inhaled or topical, are not permitted within 3 months prior to
visit one
- Current and/or previous use of the following medications:
- Finasteride (Proscar, Propecia), or Dutasteride (GI198745, AVODART) exposure
within 6 months prior to study entry are excluded.
- Any other investigational 5α-reductase inhibitors within the past 12 months.
- Anabolic steroids (subject must discontinued for 6 months prior to study entry to
be eligible)
- Drugs with antiandrogenic properties within the past 6 months (e. g,.
spironolactone, flutamide, bicalutamide, *cimetidine, *ketoconazole,
metronidazole, progestational agents) NOTE: Use of dietary and herbal
supplements (e. g., selenium, Vitamin E, saw palmetto) during the study is
discouraged but not prohibited. All dietary and herbal supplement usage will be
recorded in the CRF.
- The use of cimetidine is permitted prior to study entry. The use of topical
ketoconazole is permitted prior to and during the study.
- Prostate volume >80 cc
- Subject has had prior prostatic surgery including TUNA, TURP, TUIP, laser treatment,
thermotherapy, balloon dilatation, prosthesis, and ultrasound ablation within 3 months
of enrolment
- Severe BPH symptoms as manifested by IPSS symptom score (calculated using the first 7
questions only) of ≥25 or >20 if already on alpha blocker therapy.
- Participation in any investigational or marketed drug trial within the 30 days prior
to the first dose of study drug or anytime during the study period.
- Any unstable serious co-existing medical condition(s) including but not limited to
myocardial infarction, coronary bypass surgery, unstable angina, cardiac arrhythmias,
clinically evident congestive heart failure, or cerebrovascular accident within 6
months prior to Screening visit; uncontrolled diabetes or peptic ulcer disease which
is uncontrolled by medical management.
- Abnormal liver function test (greater than 2 times the upper limit of normal for
alanine aminotransferase [ALT], aspartate aminotransferase [AST], or alkaline
phosphatase [ALP]); or bilirubin >1. 5 times the upper limit of normal.
- Serum creatinine >1. 5 times the upper limit of normal.
- History of another malignancy within five years that could affect the diagnosis of
prostate cancer.
- History or current evidence of drug or alcohol abuse within the last 12 months.
- History of any illness (including psychiatric) that, in the opinion of the
investigator, might confound the results of the study or pose additional risk to the
subject.
- Known hypersensitivity to any 5α-reductase inhibitor or to any drug chemically related
to dutasteride.
GSK Clinical Trials Call Center, Edmonton, Alberta T5H 4B9, Canada
GSK Clinical Trials Call Center, Little Rock, Arkansas 72211, United States
GSK Clinical Trials Call Center, Victoria, British Columbia V8T 5G1, Canada
GSK Clinical Trials Call Center, Victoria, British Columbia V8V 3N1, Canada
GSK Clinical Trials Call Center, Surrey, British Columbia V3V 1N1, Canada
GSK Clinical Trials Call Center, San Bernardino, California 92404, United States
GSK Clinical Trials Call Center, Modesto, California 95350, United States
GSK Clinical Trials Call Center, Laguna Woods, California 92637, United States
GSK Clinical Trials Call Center, Torrance, California 90505, United States
GSK Clinical Trials Call Center, Mission Hills, California 91345, United States
GSK Clinical Trials Call Center, Beverly Hills, California 90210, United States
GSK Clinical Trials Call Center, Wheat Ridge, Colorado 80033, United States
GSK Clinical Trials Call Center, Denver, Colorado 80210, United States
GSK Clinical Trials Call Center, Trumbull, Connecticut 06611, United States
GSK Clinical Trials Call Center, New Britain, Connecticut 06052, United States
GSK Clinical Trials Call Center, Washington, District of Columbia 20307, United States
GSK Clinical Trials Call Center, Jacksonville, Florida 32224, United States
GSK Clinical Trials Call Center, Orlando, Florida 32803, United States
GSK Clinical Trials Call Center, Tallahassee, Florida 32308, United States
GSK Clinical Trials Call Center, Clearwater, Florida 33761, United States
GSK Clinical Trials Call Center, Roswell, Georgia 30076, United States
GSK Clinical Trials Call Center, Coeur d'Alene, Idaho 83814, United States
GSK Clinical Trials Call Center, Chicago, Illinois 60612, United States
GSK Clinical Trials Call Center, Melrose Park, Illinois 60153, United States
GSK Clinical Trials Call Center, Fort Wayne, Indiana 46825, United States
GSK Clinical Trials Call Center, Evansville, Indiana 47714, United States
GSK Clinical Trials Call Center, Overland Park, Kansas 66211, United States
GSK Clinical Trials Call Center, Shreveport, Louisiana 71106, United States
GSK Clinical Trials Call Center, Annapolis, Maryland 21401, United States
GSK Clinical Trials Call Center, Greenbelt, Maryland 20770, United States
GSK Clinical Trials Call Center, Watertown, Massachusetts 02472, United States
GSK Clinical Trials Call Center, Edina, Minnesota 55435, United States
GSK Clinical Trials Call Center, Sartell, Minnesota 56377, United States
GSK Clinical Trials Call Center, Jackson, Mississippi 39202, United States
GSK Clinical Trials Call Center, St. Louis, Missouri 63136, United States
GSK Clinical Trials Call Centre, Las Vegas, Nevada 89109, United States
GSK Clinical Trials Call Center, Fredericton, New Brunswick E3B 5B8, Canada
GSK Clinical Trials Call Center, Marlton, New Jersey 08053, United States
GSK Clinical Trials Call Center, Albuquerque, New Mexico 87109, United States
GSK Clinical Trials Call Center, Syracuse, New York 13210, United States
GSK Clinical Trials Call Center, Orchard Park, New York 14127, United States
GSK Clinical Trials Call Center, New York, New York 10016, United States
GSK Clinical Trials Call Center, Elmont, New York 11003, United States
GSK Clinical Trials Call Center, Albany, New York 12208, United States
GSK Clinical Trials Call Center, Garden City, New York 11530, United States
GSK Clinical Trials Call Center, New York, New York 10016, United States
GSK Clinical Trials Call Center, Carmel, New York 10512, United States
GSK Clinical Trials Call Center, Salisbury, North Carolina 28144, United States
GSK Clinical Trials Call Center, Winston-Salem, North Carolina 27103, United States
GSK Clinical Trials Call Center, Greensboro, North Carolina 27403, United States
GSK Clinical Trials Call Center, Charlotte, North Carolina 28204, United States
GSK Clinical Trials Call Center, Columbus, Ohio 43214, United States
GSK Clinical Trials Call Center, Brantford, Ontario N3R 4N3, Canada
GSK Clinical Trials Call Center, Burlington, Ontario L7S 1V2, Canada
GSK Clinical Trials Call Center, Scarborough, Ontario M1P 2T7, Canada
GSK Clinical Trials Call Center, Barrie, Ontario L4M 7G1, Canada
GSK Clinical Trials Call Center, Toronto, Ontario M6A 3B5, Canada
GSK Clinical Trials Call Center, Oakville, Ontario L6H 3P1, Canada
GSK Clinical Trials Call Center, Kitchener, Ontario N2M 5N4, Canada
GSK Clinical Trials Call Center, Toronto, Ontario M5G 2M9, Canada
GSK Clinical Trials Call Center, North Bay, Ontario P1B 4Z2, Canada
GSK Clinical Trials Call Center, Burlington, Ontario L7N 3V2, Canada
GSK Clinical Trials Call Center, Springfield, Oregon 97477, United States
GSK Clinical Trials Call Center, Portland, Oregon 97205, United States
GSK Clinical Trials Call Centre, Bala Cynwyd, Pennsylvania 19004, United States
GSK Clinical Trials Call Center, Philadelphia, Pennsylvania 19107, United States
GSK Clinical Trials Call Center, Lancaster, Pennsylvania 17604, United States
GSK Clinical Trials Call Center, Trois Rivieres, Quebec G9A 3V7, Canada
GSK Clinical Trials Call Center, Laval, Quebec H7G 2E6, Canada
GSK Clinical Trials Call Center, Montreal, Quebec H3S 1Z1, Canada
GSK Clinical Trials Call Center, Greenfield Park, Quebec J4V 2H3, Canada
GSK Clinical Trials Call Center, Pointe-Claire, Quebec H9R 4S3, Canada
GSK Clinical Trials Call Center, Quebec City, Quebec G1R 2J6, Canada
GSK Clinical Trials Call Center, Memphis, Tennessee 38119, United States
GSK Clinical Trials Call Center, Nashville, Tennessee 37232, United States
GSK Clinical Trials Call Center, Temple, Texas 76508, United States
GSK Clinical Trials Call Center, San Antonio, Texas 78229, United States
GSK Clinical Trials Call Center, San Antonio, Texas 78229, United States
GSK Clinical Trials Call Center, Salt Lake City, Utah 84124, United States
GSK Clinical Trials Call Center, Burlington, Vermont 05401, United States
GSK Clinical Trials Call Center, Williamsburg, Virginia 23185, United States
GSK Clinical Trials Call Center, Richmond, Virginia 23235, United States
GSK Clinical Trials Call Center, Virginia Beach, Virginia 23454, United States
GSK Clinical Trials Call Center, Spokane, Washington 99202, United States
GSK Clinical Trials Call Center, Seattle, Washington 98166, United States
GSK Clinical Trials Call Center, Seattle, Washington 98101, United States
